FDA issued a Warning Letter to Taro Pharmaceuticals, Inc on 2/5/2009 as a result of this inspection.
483 Taro Pharmaceuticals Jul 2008
483 Taro Pharmaceuticals Jul 2008$119 - Not in Stock
FDA investigators audited the Taro Pharmaceuticals - Brampton, Canada facility and issued inspectional observations (via FDA 483) on 31 Jul 2008.
- Category: Human Drugs
- Inspection end: 31 Jul 2008
- Location: Brampton, Canada
- FEI: 3002808384
Pre-Order Not Available